Siwen Hu‐Lieskovan

1. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
   2020/10/01 by Patrick A. Ott, Siwen Hu-Lieskovan, Siwen Hu‐Lieskovan +44 · 10 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches